Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments

By Dietrich G.   Viret J.-F.   Hess J.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 667-670

Elsevier

Access to resources Recommend Favorite

Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation

By Wang J.   Zganiacz A.   Xing Z.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2887-2898

Elsevier

Access to resources Recommend Favorite

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens

By Scheifele D.W.   Halperin S.A.   Ferguson A.C.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4720-4726

Elsevier

Access to resources Recommend Favorite

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine

By Chujoh Y.   Matsuo K.   Yoshizaki H.   Nakasatomi T.   Someya K.   Okamoto Y.   Naganawa S.   Haga S.   Yoshikura H.   Yamazaki A.   Yamazaki S.   Honda M.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 797-804

Elsevier

Access to resources Recommend Favorite

Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres

By Johansen P.   Estevez F.   Zurbriggen R.   Merkle H.P.   Gluck R.   Corradin G.   Gander B.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1047-1054

Elsevier

Access to resources Recommend Favorite